OR

Browse By

Proposal for funding susceptibility testing of contemporary Australian isolates of Pseudomonas aeruginosa and extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae (2016–2017)

Grant type:
Merck Sharp & Dohme Australia
Funded by:
Merck, Sharp & Dohme